Matthew Sj Katz

Ocular Proteomics, Llc

$219,009

Attributed

$219,009

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding mix

By agency

NIH$219,009 · 1

By mechanism

R43$219,009 · 1

Top collaborators

No co-investigators on record.

Most similar at Ocular Proteomics, Llc

Same institution · by research overlap

Bert Glaser$1,383,746

Others in their field

Other Emerging Leaders on “Angiogenesis”

Yi Tan · University Of Louisville$5,480,724
Bradley David Gelfand · University Of Virginia$5,037,924
Junjie Yao · Brigham And Women'S Hospital$4,736,402
Ye Sun · Boston Children'S Hospital$4,181,435
Sana D Karam · University Of Colorado Denver$4,039,397
Jenny Huanjiao Zhou · Yale University$3,768,750

Research focus

AngiogenesisApoptosisAssay DevelopmentBevacizumabBiochemicalBiochemical PathwayBiological MarkersBiomarker PanelBrain Hypoxia-IschemiaCell SurvivalClinicCommercializationCompanion DiagnosticsCostDesignDevice Or Instrument DevelopmentDiabetes ManagementDiabeticDiabetic RetinopathyDiagnosisDiagnostic AssayDiagnostic BiomarkerEffective TherapyAge Related Macular Degeneration

Grant awards (1)

Development and Commercialization of Predictive Biomarker Panel and In-Office Kit for the Management of Diabetic Macular Edema$219,009

R43 · FY2017 · EY · contact PI